Pulse Biosciences CS (PLSE) Stock Price, Quote & News

Company Profile

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; CellFX nsPFA Percutaneous Electrode system for soft tissue ablation in surgical setting; CellFX nsPFA Cardiac Clamp designed for use in surgical treatment of atrial fibrillation (AF); CellFX nsPFA 360° Cardiac Catheter designed to provide a circumferential, or circular, ablation in a single treatment cyc...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 510 906 4600

Website: www.pulsebiosciences.com

Address:

601 Brickell Key Drive, Suite 1080, Miami, United States

della_momentum Feb. 20 at 8:42 PM

$PLSE thin biotech quietly compressing if demand appears this has asymmetric upside

0 · Reply

RoadRunner911 Feb. 20 at 6:24 PM

$PLSE People selling because the company hasn't made money yet is short sighted. This is a long term winner. Tech is better than what exists now and safer. I'll stay.

2 · Reply

TruthBroker2 Feb. 20 at 2:30 PM

$PLSE $SMMT

0 · Reply

TruthBroker2 Feb. 20 at 11:58 AM

$PLSE

0 · Reply

nhjxie Feb. 20 at 2:53 AM

$PLSE oncology

0 · Reply

Tony_37 Feb. 20 at 1:15 AM

$FATN $NGNE $PLSE $SSTI : when Ssti $13 ? Earning next Tuesday.. insider buy millions of dollars.. barely move above $8 .. 🎁

0 · Reply

StocktwitsEarnings Feb. 19 at 10:29 PM

$PLSE Q4 '25 Earnings Results & Recap Reported GAAP EPS of -$0.26 up 16.13% YoY

0 · Reply

RoadRunner911 Feb. 19 at 10:11 PM

$PLSE Any thoughts on business call so far? Thoughts on all the SEC filings that just came out? They sound very competent so far.

1 · Reply

bob2013 Feb. 19 at 10:03 PM

$PLSE You can't build a great building on a weak foundation. ...Paul and company building a strong foundation!!!

0 · Reply

TruthBroker2 Feb. 19 at 4:39 PM

$PLSE $SMMT Time to go Green

0 · Reply

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 20, 2026, 7:00 AM EST - 14 hours ago

Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference

Feb 20, 2026, 2:54 AM EST - 18 hours ago

Pulse Biosciences, Inc. (PLSE) Q4 2025 Earnings Call Transcript

Feb 19, 2026, 4:05 PM EST - 1 day ago

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results

Feb 9, 2026, 9:18 AM EST - 11 days ago

What's Going With Pulse Biosciences Stock On Monday?

Feb 5, 2026, 7:00 PM EST - 15 days ago

Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium

Feb 4, 2026, 4:05 PM EST - 16 days ago

Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026

Feb 3, 2026, 7:00 AM EST - 17 days ago

Pulse Biosciences' nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium

Jan 15, 2026, 1:46 AM EST - 5 weeks ago

Pulse Biosciences, Inc. (PLSE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 9, 2026, 7:00 AM EST - 6 weeks ago

Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

Jan 6, 2026, 7:00 AM EST - 6 weeks ago

Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium

Dec 29, 2025, 4:05 PM EST - 7 weeks ago

Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 19, 2025, 4:05 PM EST - 2 months ago

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dec 18, 2025, 7:00 AM EST - 2 months ago

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

Dec 9, 2025, 7:00 AM EST - 2 months ago

Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology

Nov 6, 2025, 4:05 PM EST - 3 months ago

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences

Nov 5, 2025, 11:01 PM EST - 3 months ago

Pulse Biosciences, Inc. (PLSE) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 4:05 PM EST - 3 months ago

Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results

Oct 24, 2025, 7:00 AM EDT - 4 months ago

Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study

Oct 22, 2025, 4:05 PM EDT - 4 months ago

Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025

Oct 10, 2025, 7:00 AM EDT - 4 months ago

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Oct 7, 2025, 7:00 AM EDT - 4 months ago

Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Sep 10, 2025, 7:00 AM EDT - 5 months ago

Pulse Biosciences' nPulse™ Technology to be Featured at the American Thyroid Association 2025 Annual Meeting

Sep 8, 2025, 7:00 AM EDT - 5 months ago

Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation

Sep 2, 2025, 7:00 AM EDT - 6 months ago

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

Aug 26, 2025, 7:00 AM EDT - 6 months ago

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid

Aug 12, 2025, 9:06 PM EDT - 6 months ago

Pulse Biosciences, Inc. (PLSE) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 4:05 PM EDT - 6 months ago

Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results

Aug 1, 2025, 7:00 AM EDT - 7 months ago

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference

Jul 29, 2025, 4:05 PM EDT - 7 months ago

Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025

May 10, 2025, 11:02 PM EDT - 10 months ago

Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 10 months ago

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results

May 6, 2025, 4:05 PM EDT - 10 months ago

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

May 1, 2025, 7:00 AM EDT - 10 months ago

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

Apr 24, 2025, 4:05 PM EDT - 10 months ago

Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025

Apr 23, 2025, 7:00 AM EDT - 10 months ago

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting

Mar 27, 2025, 7:46 PM EDT - 11 months ago

Pulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 4:05 PM EDT - 11 months ago

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

Mar 26, 2025, 4:05 PM EDT - 11 months ago

Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference

Mar 7, 2025, 8:00 AM EST - 1 year ago

Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025

Feb 20, 2025, 4:05 PM EST - 1 year ago

Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference

Feb 4, 2025, 8:00 AM EST - 1 year ago

Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

Jan 30, 2025, 8:00 AM EST - 1 year ago

Pulse Biosciences' Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting

Jan 21, 2025, 7:00 AM EST - 1 year ago

Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium

Jan 13, 2025, 7:00 AM EST - 1 year ago

Pulse Biosciences' Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium

Jan 10, 2025, 8:00 AM EST - 1 year ago

Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer

Jan 3, 2025, 9:00 AM EST - 1 year ago

Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 23, 2024, 4:30 PM EST - 1 year ago

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

Dec 19, 2024, 8:00 AM EST - 1 year ago

Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants

Dec 17, 2024, 8:00 AM EST - 1 year ago

Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery

della_momentum Feb. 20 at 8:42 PM

$PLSE thin biotech quietly compressing if demand appears this has asymmetric upside

0 · Reply

RoadRunner911 Feb. 20 at 6:24 PM

$PLSE People selling because the company hasn't made money yet is short sighted. This is a long term winner. Tech is better than what exists now and safer. I'll stay.

2 · Reply

TruthBroker2 Feb. 20 at 2:30 PM

$PLSE $SMMT

0 · Reply

TruthBroker2 Feb. 20 at 11:58 AM

$PLSE

0 · Reply

nhjxie Feb. 20 at 2:53 AM

$PLSE oncology

0 · Reply

Tony_37 Feb. 20 at 1:15 AM

$FATN $NGNE $PLSE $SSTI : when Ssti $13 ? Earning next Tuesday.. insider buy millions of dollars.. barely move above $8 .. 🎁

0 · Reply

StocktwitsEarnings Feb. 19 at 10:29 PM

$PLSE Q4 '25 Earnings Results & Recap Reported GAAP EPS of -$0.26 up 16.13% YoY

0 · Reply

RoadRunner911 Feb. 19 at 10:11 PM

$PLSE Any thoughts on business call so far? Thoughts on all the SEC filings that just came out? They sound very competent so far.

1 · Reply

bob2013 Feb. 19 at 10:03 PM

$PLSE You can't build a great building on a weak foundation. ...Paul and company building a strong foundation!!!

0 · Reply

TruthBroker2 Feb. 19 at 4:39 PM

$PLSE $SMMT Time to go Green

0 · Reply

TruthBroker2 Feb. 19 at 1:56 PM

$PLSE $SMMT

0 · Reply

buzzybob Feb. 19 at 1:38 PM

$PLSE Earnings preview - Institutional cash inflows continue: https://www.marketbeat.com/instant-alerts/pulse-biosciences-plse-to-release-earnings-on-thursday-2026-02-12/

0 · Reply

LeisureSuitLarry Feb. 18 at 11:17 PM

$SMMT $PLSE

0 · Reply

TruthBroker2 Feb. 18 at 10:26 PM

$PLSE

0 · Reply

buzzybob Feb. 18 at 9:25 PM

$PLSE Large purchase after hours? $26.37

1 · Reply

SadyK189 Feb. 18 at 9:04 PM

Here is my Amazing daily "Stocktwits" report 2 / 2: $PLSE $SGN $NCI $IBRX NCI Price 2.89. My post was "Looking good on daily chart. Key support at 1.95 - 2.15. Next key level to test is 3.65 - 4." It hit our desired zone went till 4.24 today IBRX Price 6.04. My post was "Initially alerted at 4.76. Key support at 4.6 - 4.9. Next key level to test is 6.6 - 6.85." It made a nice move to 8.68 today PLSE My post last night "Good close of daily candle. Key support at 17.3 - 17.85. Next key level to test is 22.9 - 24.1. Currently at 21.60" It went till 25.73 today SGN Price 0.44. My post last night "Looking good on 4hours chart. Key support at 0.32 - 0.36. Next key level to test is 0.56 - 0.6." It went till 0.5446 today

1 · Reply

zzzdoc01 Feb. 18 at 8:44 PM

$PLSE can anyone else not buy this security through their brokerage account? I have vanguard and they will not let me place a trade without calling them first and it pisses me off...

3 · Reply

TruthBroker2 Feb. 18 at 7:59 PM

$PLSE Be Lookin Good

0 · Reply

Carl81 Feb. 18 at 4:54 PM

$PLSE

0 · Reply

CapitalCommentary Feb. 18 at 4:00 PM

$PLSE Pulse Biosciences develops electroporation-based medical devices. Clinical adoption is early-stage. Commercial proof is required for valuation expansion.

0 · Reply

bob2013 Feb. 18 at 1:07 PM

$PLSE today is the tomorrow you worried about yesterday.. (HE KNOWS)!!!

0 · Reply

SadyK189 Feb. 17 at 9:05 PM

Here is my Amazing daily Stocktwits report 2 / 2: $SIF $FSLY $ADAG $PLSE ADAG Price 2.46. My post was "Looking good on daily chart. Key support at 1.80 - 2.05. Next key level to test is 3- 3.30." It hit our desired zone and went till 3.44 today SIF Price 8.74. My post was "Looking good on daily chart. Key support at 7.3 - 7.8. Next key level to test is 9.75 - 10.30." It made a nice move to 13.37 today FSLY Price at 16.40. My post was"Looking good on 4hours chart. key support at 13.1 - 13.8. Next key level to test is 17.6 - 18.15." It hit our desired zone and went till 19.21 today PLSE My post was "Good close of daily candle. Key support at 17.3 - 17.85. Next key level to test is 22.9 - 24.1. Currently at 21.60" It went till 24.13 today

0 · Reply

Market Cap	1.73B
Revenue (ttm)	0.00
Net Income (ttm)	-53.59M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	1,034,000
Avg Vol	298,830
Day's Range	N/A - N/A
Shares Out	67.77M
Stochastic %K	93%
Beta	1.77
Analysts	Strong Sell
Price Target	$26.00